|
|
 |
BENZOIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
EPIDIOLEX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
BENZALKONIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DUEXIS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ERIVEDGE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|